Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops Protective Barrier for Public Seats (LAX-1629)


PITTSBURGH, April 16, 2024 /PRNewswire/ -- "I wanted to create a protective covering that can be used with any public seating," said an inventor, from Cerritos, Calif., "so I invented the TRANSIT SEAT PAD. My design eliminates the need to wipe seats or find a cleaner seat to use."

The patent-pending invention provides a protective seat barrier when using public transportation or attending a sporting/concert event. In doing so, it eliminates the need to directly touch the seat of a bus, train, etc. As a result, it protects against germs, bacteria, dirt, stains, wetness, and dust. It also increases comfort and convenience. The invention features a portable design that is quick and easy to set up so it is ideal for travelers, commuters, sports fans, etc. Additionally, a prototype model is available upon request.

The original design was submitted to the Los Angeles sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-LAX-1629, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 17:21
On Tuesday, May 28, the Second Gentleman will deliver remarks at an event to raise awareness about the physical and mental health challenges affecting young people. The Second Gentleman will uplift the Biden-Harris Administration's actions to tackle...

at 17:05
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus' Board of Directors granted inducement awards to Eric Olson, in connection...

at 16:46
Vanda Pharmaceuticals Inc. (Vanda) today announced that the Company's Board of Directors (the "Board") carefully reviewed the revised unsolicited proposal from Future Pak, LLC ("FP") to acquire the Company for $7.25 to $7.75 per share in cash plus...

at 16:45
Nutex Health Inc. ("Nutex Health" or the "Company") , a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks,...

at 16:40
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company's Board of...

at 16:30
Rakovina Therapeutics Inc. ("Rakovina" or the "Company") announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust Company dated May 29, 2023 (the "Indenture"), certain holders (each, a...



News published on and distributed by: